JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Scope & Guideline

Bridging research and practice in pediatric mental health.

Introduction

Welcome to your portal for understanding JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1044-5463
PublisherMARY ANN LIEBERT, INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1990 to 2024
AbbreviationJ CHILD ADOL PSYCHOP / J. Child Adolesc. Psychopharmacol.
Frequency10 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801

Aims and Scopes

The Journal of Child and Adolescent Psychopharmacology focuses on the intersection of pharmacology and mental health in youth, emphasizing evidence-based practices and innovative treatment approaches. It serves as a platform for sharing research on the efficacy, safety, and psychosocial implications of psychopharmacological interventions in children and adolescents.
  1. Pharmacological Treatment of Psychiatric Disorders:
    The journal extensively covers research related to pharmacological interventions for various psychiatric conditions such as ADHD, depression, anxiety, and psychotic disorders in children and adolescents.
  2. Systematic Reviews and Meta-Analyses:
    A significant portion of publications includes systematic reviews and meta-analyses that aggregate findings from multiple studies to provide comprehensive insights into treatment efficacy and safety.
  3. Innovations in Psychopharmacology:
    The journal highlights cutting-edge research, including novel medications and treatment protocols, contributing to the advancement of psychopharmacology in pediatric populations.
  4. Longitudinal and Cohort Studies:
    Research often employs longitudinal and cohort study designs to assess the long-term effects of psychotropic medications and their impact on developmental outcomes.
  5. Pharmacogenomics and Personalized Medicine:
    The journal increasingly focuses on pharmacogenetic studies that explore genetic factors influencing medication response, aiming to enhance personalized treatment approaches for youth.
  6. Behavioral and Psychosocial Interventions:
    In addition to pharmacological studies, the journal includes research on the integration of behavioral therapies with pharmacological treatments to optimize outcomes in youth.
The Journal of Child and Adolescent Psychopharmacology is witnessing notable trends and emerging themes that reflect the evolving landscape of pediatric mental health research. These themes highlight the journal's responsiveness to contemporary issues in child and adolescent psychiatry.
  1. Innovative Treatment Modalities:
    There is a growing emphasis on exploring new treatment modalities, including the use of ketamine and transcranial magnetic stimulation for treatment-resistant depression, indicating a shift towards more innovative approaches in psychopharmacology.
  2. Pharmacogenetics and Personalized Medicine:
    Recent publications increasingly focus on pharmacogenetic factors that influence medication efficacy and safety, marking a significant trend towards personalized medicine in pediatric psychopharmacology.
  3. Impact of COVID-19 on Youth Mental Health:
    The journal has seen a rise in studies investigating the psychological impact of the COVID-19 pandemic on children and adolescents, emphasizing the need to address emerging mental health challenges.
  4. Metabolic Monitoring in Psychotropic Treatment:
    Research on metabolic monitoring in youth prescribed second-generation antipsychotics is becoming more prevalent, reflecting concerns about long-term health outcomes and the need for comprehensive care.
  5. Intersection of Mental Health and Developmental Disorders:
    There is an increasing trend in exploring the intersectionality of mental health issues with developmental disorders such as autism, highlighting the complexities of treatment in these populations.

Declining or Waning

While the journal continues to explore a wide array of topics in child and adolescent psychopharmacology, certain themes appear to be waning in prominence. This decline may reflect shifting research priorities or advancements in treatment methodologies.
  1. Traditional Antidepressant Studies:
    Research focusing solely on traditional antidepressants, particularly SSRIs without considering adjunct therapies or novel treatments, has decreased as newer modalities gain attention.
  2. Generalized Anxiety Disorder (GAD) Focus:
    While anxiety disorders remain a topic of interest, specific studies centered on GAD alone are less frequent, possibly as a result of a broader focus on anxiety as part of a spectrum of disorders.
  3. Pharmacotherapy for ADHD without Behavioral Interventions:
    There is a noticeable decline in studies examining pharmacotherapy for ADHD in isolation, with a growing emphasis on combined treatment approaches that integrate behavioral interventions.
  4. Longitudinal Studies on Medication Side Effects:
    The frequency of studies specifically focusing on long-term side effects of established medications is decreasing, potentially due to a shift towards understanding efficacy in broader treatment contexts.

Similar Journals

Journal of the Korean Academy of Child and Adolescent Psychiatry

Elevating discourse on child and adolescent psychiatry.
Publisher: KOREAN ACAD CHILD & ADOLESCENT PSYCHIATRYISSN: 1225-729XFrequency: 4 issues/year

The Journal of the Korean Academy of Child and Adolescent Psychiatry (ISSN: 1225-729X; E-ISSN: 2233-9183) stands as a pivotal resource in the fields of child and adolescent mental health, contributing significantly to the dialogue on psychiatric practices and research in South Korea and beyond. Published by the KOREAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY, this journal is recognized for its dedication to advancing the understanding of psychiatric disorders that affect children and adolescents, as evidenced by its Q3 ranking in both Pediatrics, Perinatology and Child Health and Psychiatry and Mental Health categories for 2023. Operated from Seoul, South Korea, the journal facilitates knowledge-sharing among researchers and practitioners, providing insights into clinical practices and innovative treatment methodologies. Although not openly accessible, the journal emphasizes quality over quantity in its selection of studies, making each article a valuable contribution to the field. As the journal continues to publish impactful research through 2024, it remains essential reading for those committed to the well-being of younger populations and their families.

JOURNAL OF CLINICAL PSYCHIATRY

Pioneering new frontiers in clinical psychiatry since 1978.
Publisher: PHYSICIANS POSTGRADUATE PRESSISSN: 0160-6689Frequency: 6 issues/year

The JOURNAL OF CLINICAL PSYCHIATRY is a premier publication dedicated to advancing the understanding and treatment of psychiatric disorders. Established in 1978 and published by Physicians Postgraduate Press, this esteemed journal provides a vital platform for researchers, clinicians, and mental health professionals to share innovative findings and evidence-based practices in psychiatry. With an impressive impact factor and recognized as a Q1 journal in both Medicine (miscellaneous) and Psychiatry and Mental Health, the journal ranks among the top in its field, sitting at 96th out of 567 in Scopus rankings, placing it in the 83rd percentile. The journal's commitment to high-quality, peer-reviewed articles facilitates the dissemination of knowledge crucial for advancing clinical practices and improving patient outcomes. Access to its latest research is offered through institutional subscriptions, making it an essential resource for anyone involved in the mental health sector, from seasoned practitioners to aspiring students.

Journal of Child Science

Pioneering research for the well-being of children.
Publisher: GEORG THIEME VERLAG KGISSN: 2474-5871Frequency: 1 issue/year

Journal of Child Science, published by GEORG THIEME VERLAG KG, is a pioneering academic journal dedicated to advancing knowledge in the fields of pediatrics, perinatology, and child health, with a special focus on surgical interventions involving children. Since its inception in 2017, this journal has endeavored to provide a platform for high-quality, peer-reviewed research that addresses critical topics related to child development and health care. With an ISSN of 2474-5871, it occupies a Q4 quartile ranking in both Pediatrics and Surgery as of 2023, demonstrating its growing presence in the academic community. Although currently non-open access, the journal aims to become a vital resource for healthcare professionals, researchers, and students interested in improving child health outcomes through informed and evidence-based practices. With a commitment to upholding rigor and integrity in research, Journal of Child Science stands as an essential avenue for discourse and discovery in child science and medicine.

Brazilian Journal of Psychiatry

Innovating psychiatry for improved mental health outcomes.
Publisher: ASSOC BRASILEIRA PSIQUIATRIAISSN: 1516-4446Frequency: 4 issues/year

The Brazilian Journal of Psychiatry is a prominent peer-reviewed journal dedicated to advancing the field of psychiatry and mental health, published by the Associação Brasileira de Psiquiatria. With an impressive Q2 ranking in the Psychiatry and Mental Health category for 2023 and a Scopus rank of #130 out of 567, this journal serves as a vital resource for researchers, clinicians, and students alike. Since its transition to Open Access in 1999, it has aimed to disseminate high-quality research, innovative practices, and critical insights relevant to mental health in Brazil and beyond. The journal's focus spans various topics in psychiatry, aiming to bridge the gap between research and clinical application, making it essential reading for professionals and academicians committed to improving mental health outcomes. With a commitment to fostering scholarly discourse, the Brazilian Journal of Psychiatry not only enriches the academic landscape but also enhances the practice of psychiatry through its widespread accessibility and dedication to excellence in research.

Psychiatry and Clinical Psychopharmacology

Fostering Collaboration in Psychiatric Medicine
Publisher: AVESISSN: 2475-0573Frequency: 4 issues/year

Psychiatry and Clinical Psychopharmacology, an open-access journal published by AVES since 2017, is dedicated to advancing the fields of psychiatric medicine and psychopharmacology. With an ISSN of 2475-0573 and an E-ISSN of 2475-0581, this journal aims to provide a platform for disseminating innovative research and clinical findings relevant to mental health professionals and researchers. Although it currently holds a Q3 ranking in Pharmacology (medical) and a Q4 ranking in Psychiatry and Mental Health according to the 2023 category quartiles, the journal has established itself as a significant contributor to evolving discussions in these critical fields. Based in the United Kingdom, the journal encompasses diverse topics, ranging from pharmacological treatments to novel therapeutic approaches in psychiatry, thereby appealing to a broad audience of clinicians, scientists, and students. The open-access model ensures that all research is readily available, fostering an environment of collaboration and knowledge-sharing as the journal converges until 2024 to encompass the latest advancements in both pharmacology and clinical psychopharmacology.

Current Psychiatry Reports

Advancing mental health knowledge through rigorous research.
Publisher: SPRINGERISSN: 1523-3812Frequency: 12 issues/year

Current Psychiatry Reports, published by Springer, is a premier academic journal dedicated to the dissemination of cutting-edge research in the field of psychiatry and mental health. With a significant impact factor reflecting its esteemed position at Q1 in Psychiatry, this journal ranks an impressive #35 out of 567 in its category, placing it within the 93rd percentile of psychiatric publications as per Scopus metrics. Since its inception in 1996, it has provided a vital platform for clinicians, researchers, and students to explore and discuss contemporary psychiatric issues, advancements, and methodologies. While Current Psychiatry Reports is a subscription-based journal, its robust scholarly contributions are invaluable for practitioners and scholars looking to stay abreast of developments and empirical studies that shape the field. Based in the United States, at ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY 10004, it remains an authoritative source for evidence-based insights that guide both research and clinical practice in mental health.

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Advancing the Science of Psychopharmacology
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0268-1315Frequency: 6 issues/year

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, published by Lippincott Williams & Wilkins, stands as a pivotal peer-reviewed journal in the fields of pharmacology and psychiatry. Established in 1986, it has garnered a prominent reputation with a 2023 impact factor placing it in the Q2 category for both Pharmacology and Psychiatry and Mental Health. With an impressive Scopus ranking of #227 in the Psychiatry and Mental Health category and #114 in Pharmacology, it serves as an essential platform for researchers seeking to disseminate critical findings on psychopharmacological interventions and their clinical efficacy. The journal’s rigorous peer-review process ensures that only high-quality research is published, making it a trusted resource for professionals and students alike. By focusing on the latest advancements and evidence-based practices, the INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY contributes significantly to the understanding of mental health treatments, fostering ongoing dialogue and innovation in the discipline.

Current Psychiatry Research and Reviews

Exploring the frontiers of psychiatry and mental health.
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 2666-0822Frequency: 4 issues/year

Current Psychiatry Research and Reviews is an innovative open access journal dedicated to the dynamic field of psychiatry and mental health. Published by Bentham Science Publishers Ltd, this journal provides a platform for researchers and practitioners to disseminate pivotal findings, reviews, and advancements in psychiatric research. While the journal currently holds a Q4 status in the Psychiatry and Mental Health category, it seeks to elevate standards with interdisciplinary contributions aimed at improving patient outcomes and treatment methodologies. With a publication window spanning from 2019 to 2024, the journal aims to enhance global discussions in mental health sciences, encouraging submissions that explore evidence-based practices, innovative therapeutic techniques, and the epidemiology of mental health disorders. The journal's address in the Netherlands positions it strategically within Europe’s vibrant research community, making it an essential resource for researchers, professionals, and students alike who are invested in the evolution of psychiatric science.

Scandinavian Journal of Child and Adolescent Psychiatry and Psychology

Fostering dialogue for the well-being of future generations.
Publisher: SCIENDOISSN: 2245-8875Frequency: 3 issues/year

The Scandinavian Journal of Child and Adolescent Psychiatry and Psychology is a premier platform for disseminating significant research in the fields of child and adolescent mental health. Published by SCIENDO, this journal has embraced an Open Access model since 2013, promoting wider accessibility to vital findings and discussions in this pivotal area of study. With a unique focus on issues facing young individuals, it aims to bridge gaps between research, clinical practice, and policy-making. The journal invites submissions from researchers, clinicians, and practitioners worldwide, ensuring a diverse range of perspectives and contributions. By fostering scholarly dialogue and innovation, it plays an essential role in advancing knowledge and improving outcomes in child and adolescent psychiatry and psychology, making it a crucial resource for anyone invested in the mental well-being of young populations.

Research on Child and Adolescent Psychopathology

Championing evidence-based practices for youth well-being.
Publisher: SPRINGERISSN: 2730-7166Frequency: 8 issues/year

Research on Child and Adolescent Psychopathology, with ISSN 2730-7166 and E-ISSN 2730-7174, is a premier academic journal published by Springer, dedicated to advancing the understanding of psychological issues affecting children and adolescents. With an impressive Q1 ranking in both Developmental and Educational Psychology and Psychiatry and Mental Health in 2023, this journal serves as a crucial platform for researchers, practitioners, and students alike, focusing on evidence-based studies, innovative interventions, and the latest trends in child and adolescent mental health. As an Open Access journal, it ensures broader dissemination of knowledge, fostering collaboration and awareness among professionals across disciplines. Rooted in its commitment to tackling critical developmental challenges, Research on Child and Adolescent Psychopathology is not just a publication; it is a vital resource for those dedicated to improving mental health outcomes for young populations in the United States and beyond. Join the conversation as we explore new frontiers in understanding and addressing psychopathological issues.